ZIMMER BIOMET HOLDINGS INC (ZBH) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:ZBH - US98956P1021 - Common Stock
92.84 USD
-1.44 (-1.53%)
ChartMill assigns a Buy % Consensus number of 70% to ZBH. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 105.22. This target is 13.34% above the current price.
ZBH was analyzed by 34 analysts. The buy percentage consensus is at 70. So analysts seem to be have mildly positive about ZBH.
In the previous month the buy percentage consensus was at a similar level.
ZBH was analyzed by 34 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-10 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-11-06 | UBS | Maintains | Sell -> Sell |
| 2025-11-06 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-06 | Barclays | Maintains | Underweight -> Underweight |
| 2025-11-06 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2025-11-05 | BTIG | Maintains | Buy -> Buy |
| 2025-11-05 | Barclays | Maintains | Underweight -> Underweight |
| 2025-10-22 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-10-13 | BTIG | Maintains | Buy -> Buy |
| 2025-10-07 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-09-19 | Stifel | Maintains | Buy -> Buy |
| 2025-09-18 | Rothschild & Co | Initiate | Buy |
| 2025-08-08 | UBS | Maintains | Sell -> Sell |
| 2025-08-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-08-08 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-07-08 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-05-12 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-05-07 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-05-06 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-05-06 | Stifel | Maintains | Buy -> Buy |
| 2025-05-06 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-06 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-05-06 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-05-06 | Baird | Maintains | Outperform -> Outperform |
| 2025-05-06 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-05-06 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-10 | Barclays | Maintains | Underweight -> Underweight |
| 2025-02-10 | Truist Securities | Reiterate | Hold -> Hold |
| 2025-02-07 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-02-07 | Needham | Reiterate | Hold -> Hold |
ZIMMER BIOMET HOLDINGS INC / ZBH FAQ
What do analysts expect the price target to be for ZIMMER BIOMET HOLDINGS INC (ZBH)?
34 analysts have analysed ZBH and the average price target is 105.22 USD. This implies a price increase of 13.34% is expected in the next year compared to the current price of 92.84.
What is the consensus rating for ZIMMER BIOMET HOLDINGS INC (ZBH) stock?
The consensus rating for ZIMMER BIOMET HOLDINGS INC (ZBH) is 70 / 100 . This indicates that analysts generally have a neutral outlook on the stock.